Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Samir H. Patel MD"'
Autor:
Samir H. Patel MD, Sasha Ebrahimi PhD, Donald W. Northfelt MD, Timothy E. Mathews FNP-BC, Farhia M. Omar MPH, Erika D. Martinez MBA, Todd A. DeWees PhD, Janet M. Okamoto PhD
Publikováno v:
Cancer Control, Vol 27 (2020)
Many American Indian (AI) and Alaska native (AN) patients do not complete guideline-concordant cancer care for the 4 most common cancers. Our aim was to better understand AI/AN attitudes toward radiation therapy (RT). Patients eligible for this surve
Externí odkaz:
https://doaj.org/article/67f21dd47bd24443abfca3b502f01c8b
Autor:
Brady S. Laughlin, MD, Sasha Ebrahimi, MD, PhD, Molly M. Voss, BA, Samir H. Patel, MD, Robert L. Foote, MD, Lisa A. McGee, MD, Joaquin Garcia, MD, Daniel J. Ma, MD, Yolanda I. Garces, MD, Michelle A. Neben Wittich, MD, Katharine A. Price, MD, Alessandra Schmitt, MD, Qihui Zhai, MD, Byron C. May, MD, Thomas H. Nagel, MD, Michael L. Hinni, MD, Ashish V. Chintakuntlawar, MBBS, PhD, Todd A. DeWees, PhD, Jean-Claude M. Rwigema, MD
Publikováno v:
Advances in Radiation Oncology, Vol 8, Iss 4, Pp 101204- (2023)
Purpose: This series reports long-term clinical outcomes of patients with salivary duct carcinoma (SDC), which is associated with a poor prognosis. Methods and Materials: Eighty-nine patients with SDC were treated with curative intent from February 5
Externí odkaz:
https://doaj.org/article/ce5c8d672a394f028680444098efe8ba
Autor:
Caitlin M. Brumfiel, MS, Meera H. Patel, BS, Bashar Aqel, MD, Michael Lehrer, MD, Samir H. Patel, MD, Mahesh Seetharam, MD
Publikováno v:
JAAD Case Reports, Vol 14, Iss , Pp 78-81 (2021)
Externí odkaz:
https://doaj.org/article/970c253306a24098a415d916989d5a5b
Autor:
Roman O. Kowalchuk, MD, Kathryn M. Van Abel, MD, Adam B. Sauer, BS, Linda X. Yin, MD, Joaquin J. Garcia, MD, William S. Harmsen, MS, Eric J. Moore, MD, Daniel L. Price, MD, Ashish V. Chintakuntlawar, MD, Katharine R. Price, MD, Scott C. Lester, MD, Michelle Neben Wittich, MD, Samir H. Patel, MD, Robert L. Foote, MD, Daniel M. Ma, MD, Alex A. Nagelschneider, MD, David M. Routman, MD
Publikováno v:
Advances in Radiation Oncology, Vol 7, Iss 4, Pp 100926- (2022)
Purpose: Human papillomavirus–associated oropharyngeal squamous cell carcinoma (HPV[+]OPSCC) requires further study to optimize the existing clinical staging system and guide treatment selection. We hypothesize that incorporation of the number of r
Externí odkaz:
https://doaj.org/article/a940f1c8ede3433dbf3bc725aa815a6b
Autor:
Jidapa Bridhikitti, MD, Jason K. Viehman, W. Scott Harmsen, Adam C. Amundson, Satomi Shiraishi, PhD, Daniel W. Mundy, PhD, Jean-Claude M. Rwigema, MD, Lisa A. McGee, MD, Samir H. Patel, MD, David M. Routman, MD, Scott C. Lester, MD, Michelle A. Neben-Wittich, MD, Yolanda I. Garces, MD, Daniel J. Ma, MD, Robert L. Foote, MD
Publikováno v:
International Journal of Particle Therapy, Vol 8, Iss 1, Pp 294-303 (2021)
Purpose: Radiation therapy (RT) is the standard treatment for patients with inoperable skin malignancies of the head and neck region (H&N), and as adjuvant treatment post surgery in patients at high risk for local or regional recurrence. This study r
Externí odkaz:
https://doaj.org/article/01168152290b425eb0bafd604f155e9d
Autor:
Wei Deng, PhD, Yunze Yang, PhD, Chenbin Liu, PhD, Martin Bues, PhD, Radhe Mohan, PhD, William W. Wong, MD, Robert H. Foote, MD, Samir H. Patel, MD, Wei Liu, PhD
Publikováno v:
International Journal of Particle Therapy, Vol 8, Iss 1, Pp 36-49 (2021)
In this review article, we review the 3 important aspects of linear-energy-transfer (LET) in intensity-modulated proton therapy (IMPT) for head and neck (H&N) cancer management. Accurate LET calculation methods are essential for LET-guided plan evalu
Externí odkaz:
https://doaj.org/article/4bb1f2dba61547a7baf46c0001ead745
Autor:
Alexander Lin, MD, John H. C. Chang, MD, Ryan S. Grover, MD, Frank J. P. Hoebers, MD, PhD, Upendra Parvathaneni, MBBS, FRANZCR, Samir H. Patel, MD, Juliette Thariat, MD, PhD, David J. Thomson, MA, MD, FACR, Johannes A. Langendijk, MD, PhD, Steven J. Frank, MD, on behalf of the International Particle Therapy Co-operative Group (PTCOG) Head and Neck Subcommittee
Publikováno v:
International Journal of Particle Therapy, Vol 8, Iss 1, Pp 84-94 (2021)
Purpose: Radiation therapy is a standard modality in the treatment for cancers of the head and neck, but is associated with significant short- and long-term side effects. Proton therapy, with its unique physical characteristics, can deliver less dose
Externí odkaz:
https://doaj.org/article/fc4a855df70048c59dc3bb7213149998
Autor:
Nathan Y. Yu, MD, Aditya Khurana, BS, Daniel J. Ma, MD, Michelle A. Neben-Wittich, MD, Michael A. Golafshar, MS, Lisa A. McGee, MD, Jean-Claude M. Rwigema, MD, Robert L. Foote, MD, Samir H. Patel, MD
Publikováno v:
International Journal of Particle Therapy, Vol 8, Iss 1, Pp 311-318 (2021)
Purpose: External beam radiotherapy is used in a subset of high-risk patients with differentiated thyroid cancer (DTC). Recurrent, radioactive iodine (RAI)–refractory DTC carries a poor prognosis. We report our initial experience of intensity-modul
Externí odkaz:
https://doaj.org/article/c0c3ce522081416e9d677c92c01a76f8
Autor:
Grace L. Smith, MD, PhD, MPH, Shuangshuang Fu, PhD, Matthew S. Ning, MD, MPH, Diem-Khanh Nguyen, BA, Paul M. Busse, MD, PhD, Robert L. Foote, MD, Adam S. Garden, MD, Gary B. Gunn, MD, Clifton D. Fuller, MD, PhD, William H. Morrison, MD, Gregory M. Chronowski, MD, Shalin J. Shah, MD, Lauren L. Mayo, MD, Jack Phan, MD, PhD, Jay P. Reddy, PhD, James W. Snider III, MD, Samir H. Patel, MD, Sanford R. Katz, MD, Alexander Lin, MD, Nasiruddin Mohammed, MD, Roi Dagan, MD, MS, Nancy Y. Lee, MD, David I. Rosenthal, MD, Steven J. Frank, MD
Publikováno v:
International Journal of Particle Therapy, Vol 8, Iss 1, Pp 319-327 (2021)
Purpose: We compared work outcomes in patients with oropharyngeal cancer (OPC), randomized to intensity-modulated proton (IMPT) versus intensity-modulated photon therapy (IMRT) for chemoradiation therapy (CRT). Patients and Methods: In 147 patients w
Externí odkaz:
https://doaj.org/article/a0821a77b6fa49088c63c75462436811
Autor:
Mike Hernandez, MS, J. Jack Lee, PhD, Beow Y. Yeap, ScD, Rong Ye, MS, Robert L. Foote, MD, Paul Busse, MD, PhD, Samir H. Patel, MD, Roi Dagan, MD, James Snider, MD, Nasiruddin Mohammed, MD, MBA, Alexander Lin, MD, Pierre Blanchard, MD, PhD, Scott B. Cantor, PhD, Menna Y. Teferra, MS, Kate Hutcheson, PhD, Pablo Yepes, PhD, Radhe Mohan, PhD, Zhongxing Liao, MD, Thomas F. DeLaney, MD, Steven J. Frank, MD
Publikováno v:
Advances in Radiation Oncology, Vol 6, Iss 2, Pp 100635- (2021)
Purpose: This study hypothesized that insurance denial would lead to bias and loss of statistical power when evaluating the results from an intent-to-treat (ITT), per-protocol, and as-treated analyses using a simulated randomized clinical trial compa
Externí odkaz:
https://doaj.org/article/b12c4a70c7db456e8bdeb25effe791bb